Regarding the role of CD96 in the regulation of T cell functionality, tumor growth is better controlled by CD96-negative CD8+ T cells compared to CD96-positive CD8+ T cells in murine models of colon cancer, melanoma, and fibrosarcoma [91]. This evidence concerns the gene CD8A and colonic neoplasm.